Pilot study of the efficacy and hepatic safety of raltegravir-based and efavirenz-based regimens when given in combination with tenofovir and emtricitabine in antiretroviral-naïve HIV-infected subjects co-infected with hepatitis C

eagle-i ID

Resource Type

Properties

1. Intervention

   Raltegravir-based and Efavirenz-based Regimens when Given in Combination with Tenofovir and Emtricitabine

2. Additional Topic(s)

   HIV therapeutics in HIV and hepatitis C coinfection

3. Resource Description

   An open-label, randomized clinical trial

4. Contact

   Shikuma, Cecilia

5. PI

   Shikuma, Cecilia

6. Topic

   hepatitis C

7. Topic

   Human immunodeficiency virus infectious disease

8. Study Population

   Treatment-naive individuals aged >18 who are coinfected with HIV and hepatitis C and meet Viet Nam Ministry of Health criteria to inititate antiretroviral therapy (CD4 <250 or WHO stage III or IV disease)

9. Phase

   Phase 4 clinical trial

10. Performed by

    Shikuma Laboratory